Concourse Financial Group Securities’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25
Closed -$432 2220
2022
Q2
$0 Sell
25
-7
-22% -$133 ﹤0.01% 2284
2022
Q1
$1K Hold
32
﹤0.01% 2122
2021
Q4
$1K Hold
32
﹤0.01% 2313
2021
Q3
$1K Hold
32
﹤0.01% 2339
2021
Q2
$1K Hold
32
﹤0.01% 2305
2021
Q1
$1K Buy
32
+3
+10% +$68 ﹤0.01% 2269
2020
Q4
$1K Buy
+29
New +$533 ﹤0.01% 2213
2020
Q2
Sell
-64
Closed -$1.59K 2206
2020
Q1
$2K Hold
64
﹤0.01% 1912
2019
Q4
$2K Hold
64
﹤0.01% 1910
2019
Q3
$1K Hold
64
﹤0.01% 1677
2019
Q2
$2K Buy
+64
New +$2.01K ﹤0.01% 2017

Other funds holding PAHC

Concourse Financial Group Securities's PAHC Position: Q3 2022 in Review

Concourse Financial Group Securities sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 25 shares — an estimated $432 sold.

Concourse Financial Group Securities first reported a position in PAHC in Q2 2019 and held it in 11 quarters. The position peaked at $2K in Q1 2020. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • Concourse Financial Group Securities reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 25 Phibro Animal Health shares in Q3 2022, an estimated $432.
  • Concourse Financial Group Securities first reported a position in Phibro Animal Health in Q2 2019 and held it in 11 quarters.
  • Concourse Financial Group Securities's Phibro Animal Health position peaked at $2K in Q1 2020.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on Concourse Financial Group Securities's 13F filing for Q3 2022, filed 15 Nov 2022.